Rice Hall James & Associates’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-297,494
Closed -$10.4M 269
2019
Q2
$10.4M Sell
297,494
-28,387
-9% -$918K 0.35% 101
2019
Q1
$9.55M Sell
325,881
-170,067
-34% -$4.82M 0.31% 110
2018
Q4
$12.8M Buy
495,948
+3,956
+0.8% +$137K 0.47% 86
2018
Q3
$17.3M Sell
491,992
-10,696
-2% -$426K 0.62% 61
2018
Q2
$20.6M Sell
502,688
-23,333
-4% -$941K 0.75% 38
2018
Q1
$20.6M Sell
526,021
-5,280
-1% -$194K 0.8% 41
2017
Q4
$17.3M Sell
531,301
-55,121
-9% -$1.91M 0.68% 59
2017
Q3
$28M Sell
586,422
-24,170
-4% -$1.18M 1.24% 13
2017
Q2
$30.2M Buy
+610,592
New +$27M 1.31% 9
2016
Q4
Sell
-37,728
Closed -$1.87M 297
2016
Q3
$1.87M Sell
37,728
-675
-2% -$35.2K 0.1% 193
2016
Q2
$2.13M Buy
38,403
+6,241
+19% +$365K 0.12% 165
2016
Q1
$1.77M Buy
+32,162
New +$1.84M 0.1% 192

Other funds holding ACHC

Rice Hall James & Associates's ACHC Position: Q3 2019 in Review

Rice Hall James & Associates sold out of Acadia Healthcare (ACHC) in Q3 2019, closing a stake of 297,494 shares — an estimated $10.4M sold.

Rice Hall James & Associates first reported a position in ACHC in Q1 2016 and held it in 12 quarters. The position peaked at $30.2M in Q2 2017. 226 funds tracked by Wall St. Rank hold ACHC as of Q3 2019.

  • Rice Hall James & Associates reported no remaining Acadia Healthcare position as of Q3 2019 after selling out during the quarter.
  • Rice Hall James & Associates sold 297,494 Acadia Healthcare shares in Q3 2019, an estimated $10.4M.
  • Rice Hall James & Associates first reported a position in Acadia Healthcare in Q1 2016 and held it in 12 quarters.
  • Rice Hall James & Associates's Acadia Healthcare position peaked at $30.2M in Q2 2017.
  • 226 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2019.

Based on Rice Hall James & Associates's 13F filing for Q3 2019, filed 30 Oct 2019.